Endoshunt
2 known investors
EndoShunt develops a length-adjustable vascular occlusion catheter designed to control hemorrhage in traumatic vascular injuries, with manufactured prototypes tested in benchtop and in vivo studies. The medical device is pursuing FDA 510(k) clearance.